Must a rise in AST or ALT of thrice the higher limit of standard or greater persist, withdrawal of cerivastatin sodium therapy is suggested. Rhabdomyolysis with renal dysfunction secondary to myoglobinuria have already been documented with other HMG-CoA reductase inhibitors. This has not been not